148 related articles for article (PubMed ID: 24465811)
41. Results of a prospective randomised trial comparing conventional radiotherapy to split course bifractionated radiation therapy in patients with nasopharyngeal carcinoma.
Daoud J; Toumi N; Siala W; Ghorbel A; Drira MM; Frikha M
Radiother Oncol; 2007 Oct; 85(1):17-23. PubMed ID: 17343938
[TBL] [Abstract][Full Text] [Related]
42. [Analysis of related factors of nasosinusitis after radiotherapy for nasopharyngeal carcinoma].
Zhang XH; Huang JN; Fu XJ; Zhan ST
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Dec; 39(12):730-2. PubMed ID: 15813015
[TBL] [Abstract][Full Text] [Related]
43. Fractionated stereotactic radiotherapy for 136 patients with locally residual nasopharyngeal carcinoma.
Liu F; Xiao JP; Xu GZ; Gao L; Xu YJ; Zhang Y; Jiang XS; Yi JL; Luo JW; Huang XD; Huan FK; Fang H; Wan B; Li YX
Radiat Oncol; 2013 Jun; 8():157. PubMed ID: 23806065
[TBL] [Abstract][Full Text] [Related]
44. Minimally invasive surgery alone compared with intensity-modulated radiotherapy for primary stage I nasopharyngeal carcinoma.
Liu YP; Lv X; Zou X; Hua YJ; You R; Yang Q; Xia L; Guo SY; Hu W; Zhang MX; Chen SY; Lin M; Xie YL; Liu LZ; Sun R; Huang PY; Fan W; Guo X; Hong MH; Chen MY
Cancer Commun (Lond); 2019 Nov; 39(1):75. PubMed ID: 31730020
[TBL] [Abstract][Full Text] [Related]
45. Critical analysis of locoregional failures following intensity-modulated radiotherapy for nasopharyngeal carcinoma.
Orlandi E; Tomatis S; Potepan P; Bossi P; Mongioj V; Carrara M; Palazzi M; Franceschini M; Bergamini C; Locati L; Iannacone E; Guzzo M; Ibba T; Crippa F; Licitra L; Pignoli E; Fallai C
Future Oncol; 2013 Jan; 9(1):103-14. PubMed ID: 23252567
[TBL] [Abstract][Full Text] [Related]
46. How successful is high-dose (> or = 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma?
Teo PM; Kwan WH; Chan AT; Lee WY; King WW; Mok CO
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):897-913. PubMed ID: 9531376
[TBL] [Abstract][Full Text] [Related]
47. Long-term outcomes and failure patterns of patients with nasopharyngeal carcinoma staged by magnetic resonance imaging in intensity-modulated radiotherapy era: The Zhejiang Cancer Hospital's experience.
Jiang F; Jin T; Feng XL; Jin QF; Chen XZ
J Cancer Res Ther; 2015 Oct; 11 Suppl 2():C179-84. PubMed ID: 26506872
[TBL] [Abstract][Full Text] [Related]
48. A retrospective dosimetry study of intensity-modulated radiotherapy for nasopharyngeal carcinoma: radiation-induced brainstem injury and dose-volume analysis.
Yao CY; Zhou GR; Wang LJ; Xu JH; Ye JJ; Zhang LF; He X; Chen ZZ; Huang SF
Radiat Oncol; 2018 Oct; 13(1):194. PubMed ID: 30285884
[TBL] [Abstract][Full Text] [Related]
49. Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities.
Sun X; Su S; Chen C; Han F; Zhao C; Xiao W; Deng X; Huang S; Lin C; Lu T
Radiother Oncol; 2014 Mar; 110(3):398-403. PubMed ID: 24231245
[TBL] [Abstract][Full Text] [Related]
50. Forty-six cases of nasopharyngeal carcinoma treated with 50 Gy radiotherapy plus hematoporphyrin derivative: 20 years of follow-up and outcomes from the Sun Yat-sen University Cancer Center.
Xu BQ; Tu ZW; Tao YL; Liu ZG; Li XH; Yi W; Jiang CB; Xia YF
Chin J Cancer; 2016 Apr; 35():37. PubMed ID: 27056488
[TBL] [Abstract][Full Text] [Related]
51. Clinical observation of 73 nasopharyngeal carcinoma patients treated by helical tomotherapy: the China experience.
Ren G; Du L; Ma L; Feng LC; Zhou GX; Qu BL; Xu SP; Xie CB; Ou GM; Li F; Zhang XX; Yang J
Technol Cancer Res Treat; 2011 Jun; 10(3):259-66. PubMed ID: 21517132
[TBL] [Abstract][Full Text] [Related]
52. Advantages of intensity modulated radiotherapy in recurrent T1-2 nasopharyngeal carcinoma: a retrospective study.
Qiu S; Lu J; Zheng W; Xu L; Lin S; Huang C; Xu Y; Huang L; Pan J
BMC Cancer; 2014 Nov; 14():797. PubMed ID: 25366703
[TBL] [Abstract][Full Text] [Related]
53. The Five-Year Survival Rate of Patients with Nasopharyngeal Carcinoma Based on Tumor Response after Receiving Neoadjuvant Chemotherapy, Followed by Chemoradiation, in Indonesia: A Retrospective Study.
Dwijayanti F; Prabawa A; Besral ; Herawati C
Oncology; 2020; 98(3):154-160. PubMed ID: 31995803
[TBL] [Abstract][Full Text] [Related]
54. Patterns of local-regional failure after primary intensity modulated radiotherapy for nasopharyngeal carcinoma.
Kong F; Ying H; Du C; Huang S; Zhou J; Chen J; Sun L; Chen X; Hu C
Radiat Oncol; 2014 Feb; 9():60. PubMed ID: 24552293
[TBL] [Abstract][Full Text] [Related]
55. Risk, pattern and survival impact of second primary tumors in patients with nasopharyngeal carcinoma following definitive intensity-modulated radiotherapy.
Chow JCH; Au KH; Mang OWK; Cheung KM; Ngan RKC
Asia Pac J Clin Oncol; 2019 Feb; 15(1):48-55. PubMed ID: 29932287
[TBL] [Abstract][Full Text] [Related]
56. Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost.
Ou X; Zhou X; Shi Q; Xing X; Yang Y; Xu T; Shen C; Wang X; He X; Kong L; Ying H; Hu C
Oncotarget; 2015 Nov; 6(35):38381-97. PubMed ID: 26485757
[TBL] [Abstract][Full Text] [Related]
57. Clinical study of the time of repeated computed tomography and replanning for patients with nasopharyngeal carcinoma.
Gai X; Wei Y; Tao H; Zhu J; Li B
Oncotarget; 2017 Apr; 8(16):27529-27540. PubMed ID: 28404877
[TBL] [Abstract][Full Text] [Related]
58. Improvement of local control of T3 and T4 nasopharyngeal carcinoma by hyperfractionated radiotherapy and concomitant chemotherapy.
Jian JJ; Cheng SH; Tsai SY; Yen KC; Chu NM; Chan KY; Tan TD; Cheng JC; Lin YC; Leu SY; Hsieh CI; Tsou MH; Lin CY; Huang AT
Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):344-52. PubMed ID: 12023138
[TBL] [Abstract][Full Text] [Related]
59. Individualization of Clinical Target Volume Delineation Based on Stepwise Spread of Nasopharyngeal Carcinoma: Outcome of More Than a Decade of Clinical Experience.
Sanford NN; Lau J; Lam MB; Juliano AF; Adams JA; Goldberg SI; Lu HM; Lu YC; Liebsch NJ; Curtin HD; Chan AW
Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):654-668. PubMed ID: 30712708
[TBL] [Abstract][Full Text] [Related]
60. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
